SCHEMBL23535749

SCHEMBL23535749

COC(=O)c1ccc2c(c1)c(C)nn2C1CS(=O)(=O)C1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.40
▸ ALDH1A1 P00352 3/20 0.39
▸ RPS6KB1 P23443 1/20 0.37
▸ HPGD P15428 2/20 0.37
▸ HSD17B10 Q99714 1/20 0.37
▸ FGFR1 P11362 1/20 0.37
▸ ATM Q13315 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ NPSR1 Q6W5P4 1/20 0.37
▸ GAA P10253 2/20 0.37
▸ MAPT P10636 1/20 0.37
▸ SCARB1 Q8WTV0 2/20 0.36
▸ DYRK1A Q13627 1/20 0.36
▸ CA12 O43570 1/20 0.36
▸ CA1 P00915 1/20 0.36
▸ CA2 P00918 1/20 0.36
▸ CA7 P43166 1/20 0.36
▸ XDH P47989 1/20 0.36
▸ CA9 Q16790 1/20 0.36
▸ CA14 Q9ULX7 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30159583 1.00 KDM4E (0.40) KDM4EALDH1A1RPS6KB1HPGDHSD17B10
SCHEMBL23535751 0.92 KDM4E (0.39) KDM4EALDH1A1RPS6KB1HPGDHSD17B10
SCHEMBL23535648 0.88 TEAD1 (0.46) KDM4EALDH1A1HPGDHSD17B10GAA
SCHEMBL28962406 0.85 CHRNB2 (0.40) KDM4EALDH1A1RPS6KB1HPGDHSD17B10
SCHEMBL30159511 0.85 KDM4E (0.43) KDM4EALDH1A1RPS6KB1HPGDHSD17B10
SCHEMBL23535820 0.85 KDM4E (0.43) KDM4EALDH1A1RPS6KB1HPGDHSD17B10
SCHEMBL23559710 0.85 KDM4E (0.40) KDM4EALDH1A1RPS6KB1HPGDHSD17B10
SCHEMBL30864306 0.81 KDM4E (0.43) KDM4EALDH1A1RPS6KB1HPGDHSD17B10
SCHEMBL28962407 0.79 NPC1 (0.39) KDM4EALDH1A1RPS6KB1HPGDHSD17B10
SCHEMBL23559846 0.79 AXL (0.43) KDM4EALDH1A1RPS6KB1HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230027198-A1 INHIBITORS OF ENL/AF9 YEATS THE ROCKEFELLER UNIVERSITY 2023-01-26 — — US disclosed
US-20230027198-A1 INHIBITORS OF ENL/AF9 YEATS THE ROCKEFELLER UNIVERSITY 2023-01-26 — — US disclosed
WO-2021127166-A1 INHIBITORS OF ENL/AF9 YEATS THE ROCKEFELLER UNIVERSITY (US) 2021-06-24 — — WO disclosed
WO-2021127166-A1 INHIBITORS OF ENL/AF9 YEATS THE ROCKEFELLER UNIVERSITY (US) 2021-06-24 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230027198-A1 INHIBITORS OF ENL/AF9 YEATS MLLT3, YEATS2, MLLT1 KDM4E 84/4885ALDH1A1 2425/4885RPS6KB1 1303/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback